SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.89 CNY | +3.07% |
|
-0.21% | -14.61% |
| 22/05 | Salubris Pharmaceuticals Gets Nod to Market Hypertension Drug | MT |
| 23/04 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Evolution of the average Target Price on Shenzhen Salubris Pharmaceuticals Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
8c11d0214ee55b3e45452.dCyX0GkrGBiy3dcA6mbVjaEcV5sI2wJDBCycAzcHS3k.Qnz7uTkaKVCAkbZvoTCT3IxIE_dQgkV3XX31RXZ1AxomAa-xB0RvWYGy4w~e66d982984ccb27c04bcb6b1b59a4df1
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
27.89
CNY
Average target price
37
CNY
Spread / Average Target
+32.66%
High Price Target
41
CNY
Spread / Highest target
+47.01%
Low Price Target
33
CNY
Spread / Lowest Target
+18.32%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- 002294 Stock
- Consensus Shenzhen Salubris Pharmaceuticals Co., Ltd.
